SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
IMNR - Immune Response
An SI Board Since April 1996
Posts SubjectMarks Bans Symbol
1510 20 0 IMNR
Emcee:  Nagaraju R. Arakotaram Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
160 MJ--Here is a paragraph from a company press release of Sept 22. The Immune ResDruss-11/14/1997
159 Charles and others This is not in response to your question. Actually I am poMJ-11/11/1997
158 Anybody have a thought on the heavy insider selling at IMNR. 9 insiders have soCharles Hill-11/7/1997
157 Go to the IMNR Web Site- News flash regarding a profile of Dr. Black. I have reTed Kowalczyk-11/6/1997
156 please check ff. site for insider trading Manny Gugliuzza-11/6/1997
155 I only see one Director sold 30,000 @ $12.75 on 9/16. insidertrader.com It'laleh-11/2/1997
154 SEC Filings for the month of October indicate a series of "144" actioTed Kowalczyk-11/2/1997
153 That's irregardless to me John, It's *one* of the accepted values in oMark B. Martell, CCM-10/30/1997
152 MJ - One of my concerns is that IMNR will be out of cash by June. Their suckiJohn McCarthy-10/29/1997
151 John: Gallo's research has queaked my interest in the past and now. OMJ-10/29/1997
150 Mark - It's regardless - not that other word. You *don't* have to cheJohn McCarthy-10/28/1997
149 Mark - I am sorry I am a day late on this. Thanks for the advise and for yourJohn McCarthy-10/28/1997
148 That's true Chris. I just ASS U ME'd that you had already checked therMark B. Martell, CCM-10/28/1997
147 IMNR's web page also contains more info. but that was a pretty good summaryChris Wilkinson-10/28/1997
146 John, No problem. Call IMNR's Investor Relations personnel. She (can'Mark B. Martell, CCM-10/27/1997
145 Mark - Would you or someone on this thread explain something to me? Does RemuJohn McCarthy-10/26/1997
144 That is somewhat true. It is an overused statement however. First in can be oMark B. Martell, CCM-10/24/1997
143 It is a potential billion market, but IMNX's product (enbrel) has successfuCharles Hill-10/23/1997
142 I was encouraged by a statement made by IMNR about two months ago in which an oChris Wilkinson-10/23/1997
141 I too am betting that Remune will come through for IMNR. As for the arthritis tCharles Hill-10/23/1997
140 The FDA can speed up the apporoval process for Remune if the data is promising.Robert DeHaven-10/21/1997
139 Interim data collection point late in 1997 is the only official word I have seeChris Wilkinson-10/21/1997
138 I believe Phase III Remune trials started in March of '97 this would make ORobert DeHaven-10/21/1997
137 Koerte: Just waiting for phase III now. (eom)Robert DeHaven-10/20/1997
136 I share your opinion. Everybody knows the triple therapy has its problems with Koerte Andreas-10/13/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News